Results 11 to 20 of about 1,679,513 (310)

Insulin infusion sets associated with adverse events: strategies for improved diabetes education

open access: yesFrontiers in Medicine, 2023
IntroductionInsulin Infusion Sets (IIS) play a crucial role in ensuring the safe delivery of insulin through a Continuous Subcutaneous Insulin Infusion (CSII) for individuals with Type 1 Diabetes (T1D). Recent advancements in therapy have highlighted the
Ana Lucia Domingues Neves   +12 more
doaj   +1 more source

Efficacy and Renal Safety of Dapagliflozin in Patients with Type 2 Diabetes Mellitus Also Receiving Metformin: A Real-Life Experience

open access: yesJournal of Diabetes Research, 2018
Introduction. This study aimed at evaluating the efficacy and safety of dapagliflozin in patients with type 2 diabetes (T2D) who also received metformin in clinical practice in Italy. Methods.
Alessandro Scorsone   +8 more
doaj   +1 more source

Role of some serum biomarkers in the early detection of diabetic cardiomyopathy

open access: yesFuture Science OA, 2021
Aim: To assess the role of serum biomarkers in early prediction of diabetic cardiomyopathy. Materials and methods: The participants were three groups of Type 2 diabetes mellitus (DM) patients having diastolic dysfunction (DM-DD), systolic dysfunction (DM-
Amany H Abdelrahman   +9 more
doaj   +1 more source

Combinatorial treatment of mupirocin nanomicelle in insulin-based gel for wound healing in diabetic rats

open access: yesMedical Journal of Babylon, 2023
Background: Diabetic wounds remain an important clinical challenge over the past few decades. Nanodrug delivery systems play a crucial role in the treatment of chronic infections and wound healing.
Maysaa Banay Zubairi   +2 more
doaj   +1 more source

Acknowledgement to reviewers

open access: yesJournal of Metabolic Health, 2018
No abstract available.
Editorial Office
doaj   +1 more source

Insulin Resistance: From Mechanisms to Therapeutic Strategies

open access: yesDiabetes & Metabolism Journal, 2021
Insulin resistance is the pivotal pathogenic component of many metabolic diseases, including type 2 diabetes mellitus, and is defined as a state of reduced responsiveness of insulin-targeting tissues to physiological levels of insulin.
Shin-Hae Lee, Shi-Young Park, C. Choi
semanticscholar   +1 more source

Adipose tissue and insulin resistance in obese.

open access: yesBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021
Currently, obesity has become a global health issue and is referred to as an epidemic. Dysfunctional obese adipose tissue plays a pivotal role in the development of insulin resistance.
Bulbul Ahmed, R. Sultana, M. Greene
semanticscholar   +1 more source

Effects of concurrent training and detraining on leptin and insulin concentrations in obese children [PDF]

open access: yesفیزیولوژی ورزش و فعالیت بدنی, 2011
Aim: The aim of this study was to examine the effect of 12 weeks (3 days/week) concurrent training followed by 4 weeks detraining on leptin and insulin levels in obese boys.
سعید فاضلی فر   +1 more
doaj   +1 more source

Can early hyperglycemia affect the morbidity/mortality of very low birth weight premature infants?

open access: yesThe Turkish Journal of Pediatrics, 2021
Background. The study aimed to examine the effect of early hyperglycemia on the morbidity/mortality of very low birth weight premature infants. Methods.
Aleksandra Simovic   +7 more
doaj   +1 more source

Mechanisms of Insulin Action and Insulin Resistance.

open access: yesPhysiological Reviews, 2018
The 1921 discovery of insulin was a Big Bang from which a vast and expanding universe of research into insulin action and resistance has issued. In the intervening century, some discoveries have matured, coalescing into solid and fertile ground for ...
Max C. Petersen, G. Shulman
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy